Published in Biochim Biophys Acta on November 12, 1982
Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J (1992) 1.57
Resolution of myocardial phospholipase C into several forms with distinct properties. Biochem J (1983) 1.30
Characterization of multiple forms of phosphoinositide-specific phospholipase C purified from human platelets. Biochem J (1986) 1.19
Multiple forms of phosphoinositide-specific phospholipase C of different relative molecular masses in animal tissues. Evidence for modification of the platelet enzyme by Ca2+-dependent proteinase. Biochem J (1984) 1.12
Role of rap1B and p21ras GTPase-activating protein in the regulation of phospholipase C-gamma 1 in human platelets. Proc Natl Acad Sci U S A (1992) 1.00
Inositol phospholipid arachidonic acid metabolism in GH3 pituitary cells. Biochem J (1986) 0.83
Resolution of the phosphoinositide-specific phospholipase C isolated from porcine lymphocytes into multiple species. Partial purification of two isoenzymes. Biochem J (1987) 0.83
Characterization of phosphoinositide-specific phospholipase C from human platelets. Biochem J (1987) 0.82
Purification of two distinct types of phosphoinositide-specific phospholipase C from rat liver. Enzymological and structural studies. Biochem J (1988) 0.81
The effect of sn-2 fatty acid substitution on phospholipase C enzyme activities. Biochem J (1987) 0.78
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest (1974) 3.65
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.77
Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther (1998) 1.66
Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem (2000) 1.35
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J Biol Chem (2001) 1.30
Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol (1998) 1.28
Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J Biol Chem (1988) 1.28
Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem Biophys Res Commun (1991) 1.24
Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis (1984) 1.19
On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem Biophys Res Commun (1978) 1.14
Mechanisms of steroid oxidation by microorganisms. XIV. Pathway of cholesterol side-chain degradation. Biochemistry (1968) 1.11
Plasma secretin concentrations in fasting and postprandial state in man. Am J Dig Dis (1978) 1.09
Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest (1996) 1.07
Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids (1993) 1.04
Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding. Arch Biochem Biophys (2000) 1.03
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation (1999) 1.03
15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal (1995) 1.02
Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem Biophys Res Commun (1981) 1.01
C-22 acid intermediates in the microbiological cleavage of the cholesterol side chain. J Am Chem Soc (1967) 1.01
Synergistic stimulation of thromboxane biosynthesis by calcium ionophore and phorbol ester or thrombin in human platelets. Biochem Biophys Res Commun (1985) 1.00
Mechanisms of steroid oxidation by microorganisms. 13. C22 acid intermediates in the degradation of the cholesterol side chain. Biochemistry (1968) 1.00
The mechanism of microbial conversion of cholesterol into 17-keto steroids. J Am Chem Soc (1967) 0.99
Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Arch Biochem Biophys (1996) 0.99
Enzymatic synthesis of (15s)-[15-3h]prostaglandins and their use in the development of a simple and sensitive assay for 15-hydroxyprostaglandin dehydrogenase. Biochemistry (1976) 0.98
Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. J Biol Chem (1990) 0.98
Purification and characterization of phosphatidylinositol kinase from porcine liver microsomes. Biochim Biophys Acta (1988) 0.95
Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding. Arch Biochem Biophys (1999) 0.95
Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved. J Cell Biol (1989) 0.94
Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem Biophys Res Commun (2000) 0.94
Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenases. Biochim Biophys Acta (1985) 0.93
Thromboxanes: synthase and receptors. J Biomed Sci (1998) 0.93
Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives. Adv Prostaglandin Thromboxane Res (1980) 0.93
Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab (1994) 0.92
9-Hydroxyprostaglandin dehydrogenase from rat kidney. Purification to homogeneity and partial characterization. J Biol Chem (1980) 0.91
Squalene epoxidase of rat liver. J Biol Chem (1972) 0.91
Phorbol ester, 1,2-diacylglycerol, and collagen induce inhibition of arachidonic acid incorporation into phospholipids in human platelets. J Biol Chem (1989) 0.90
Biosynthesis of prostaglandins in rabbit kidney medulla. Properties of prostaglandin synthase. Biochem J (1976) 0.90
Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis (1998) 0.90
Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta (1994) 0.89
A radioimmunoassay for 6-ketoprostaglandin E1. Prostaglandins Leukot Med (1982) 0.89
Monoglyceride and diglyceride lipases from human platelet microsomes. Biochim Biophys Acta (1988) 0.88
Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem (1990) 0.88
Radioimmunoassay of motilin. Validation and studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of dog. Am J Dig Dis (1978) 0.88
Purification of thromboxane synthetase and evidence of two distinct mechanisms for the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid by porcine lung microsomes. Biochim Biophys Acta (1981) 0.87
Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases. J Pharmacol Exp Ther (2001) 0.87
Identification of a high affinity leukotriene C4-binding protein in rat liver cytosol as glutathione S-transferase. J Biol Chem (1986) 0.87
Rapid extraction of secretin from plasma by XAD-2 resin and its application in the radioimmunoassay of secretin. Anal Biochem (1978) 0.87
Phenylalanine 138 in the second intracellular loop of human thromboxane receptor is critical for receptor-G-protein coupling. Biochem Biophys Res Commun (1999) 0.86
Development of radioimmunoassay for thromboxane B2. Anal Biochem (1978) 0.86
Prostaglandin 9-ketoreductase/type II 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochem Biophys Res Commun (1981) 0.85
Radioimmunoassay of vasoactive intestinal polypeptide. Anal Biochem (1979) 0.85
Plasma secretin and gastrin responses to a meat meal and duodenal acidification in dogs. Am J Physiol (1976) 0.85
Immunoaffinity purification and characterization of thromboxane synthase from porcine lung. J Biol Chem (1986) 0.85
Stimulations of arachidonate release and inositol-1,4,5-triphosphate formation are mediated by distinct G-proteins in human platelets. Biochem Biophys Res Commun (1987) 0.84
Abnormal platelet response to thromboxane A2. J Clin Invest (1981) 0.84
Monoclonal antibodies to thromboxane synthase from porcine lung. Production and application to development of a tandem immunoradiometric assay. J Biol Chem (1986) 0.83
Simultaneous radioimmunoassay of Secretin and gastrin. Anal Biochem (1976) 0.83
3,4-dihydroxy-9,10-secoandrosta-1,3-5(10)-triene-9,17-dione 4,-5-dioxygenase from Nocardia restrictus. II. Kinetic studies. J Biol Chem (1970) 0.83
Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. Biochem J (1995) 0.83
Roles of the vagus in endogenous release of secretin and exocrine pancreatic secretion in dog. Adv Exp Med Biol (1978) 0.82
The role of N-glycosylation of human thromboxane A2 receptor in ligand binding. Arch Biochem Biophys (1998) 0.82
Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia (2010) 0.82
Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem Biophys Res Commun (1999) 0.82
Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester. Biochem J (1991) 0.82
Differential regulation of H- and L-ferritin messenger RNA subunits, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience (2000) 0.82
Characterization of the genomic structure and promoter of the mouse NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. Biochem Biophys Res Commun (1997) 0.82
Impairment of secretin release in celiac sprue. Am J Dig Dis (1978) 0.82
Kinetic evidence of a distinct regulatory site on 15-hydroxyprostaglandin dehydrogenase. Adv Prostaglandin Thromboxane Res (1976) 0.82
Hypoxia stimulates prostacyclin generation by dog lung in vitro. Prostaglandins Leukot Med (1982) 0.82
Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochem J (1998) 0.81
Burn injury with infection alters prostaglandin E2 synthesis and metabolism. J Trauma (1999) 0.81
Prostaglandin 9-ketoreductase and type II 15-hydroxyprostaglandin dehydrogenase from swine kidney are alternate activities of a single enzyme protein. Biochem Biophys Res Commun (1981) 0.81
A simple and sensitive assay for 9-hydroxyprostaglandin dehydrogenase. Anal Biochem (1977) 0.81
Intramolecular ADP-ribose transfer reactions and calcium signalling. Potential role of 2'-phospho-cyclic ADP-ribose in oxidative stress. Adv Exp Med Biol (1997) 0.81
Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis (1997) 0.81
Subcellular distribution of leukotriene C4 binding units in cultured bovine aortic endothelial cells. J Immunol (1986) 0.80
Observations of plasma secretin levels by radioimmunoassay in response to duodenal acidification and to a meat meal in humans. Am J Dig Dis (1976) 0.80
Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase. J Trauma (1998) 0.80
The Escherichia coli-derived Fab fragment of the IgM/kappa antibody IN-1 recognizes and neutralizes myelin-associated inhibitors of neurite growth. Eur J Biochem (1996) 0.80
Selective inhibition of thromboxane synthetase by pyridine and its derivatives. Arch Biochem Biophys (1980) 0.80
Preparation of 125I-labeled secretin of high specific radioactivity. Anal Biochem (1975) 0.80
3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase from Nocardia restrictus. I. Isolation of the enzyme and study of its physical and chemical properties. J Biol Chem (1970) 0.80
Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg (1986) 0.80
Radioimmunological assay of prostacyclin synthetase activity. Prostaglandins Med (1980) 0.80
Stimulation of cyclic nucleotide phosphodiesterase by products of phosphatidylinositol metabolism catalyzed by phospholipase A2. Arch Biochem Biophys (1982) 0.80
Functional characterization of the promoter region of the platelet-activating factor receptor gene. Identification of an initiator element essential for gene expression in myeloid cells. J Biol Chem (1995) 0.79
Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch Toxicol (1995) 0.79
Calcium stimulation of a novel 12-lipoxygenase from rat basophilic leukemia (RBL-1) cells. Biochim Biophys Acta (1984) 0.79
Serine 331 is the major site of receptor phosphorylation induced by agents that activate protein kinase G in HEK 293 cells overexpressing thromboxane receptor alpha. Arch Biochem Biophys (2001) 0.79
NAD+-dependent 15-hgydroxyprostaglandin dehydrogenase from porcine kidney. II. Kinetic studies. Biochim Biophys Acta (1980) 0.79
Prostaglandin E2 receptor EP3alpha subtype: the role of N-glycosylation in ligand binding as revealed by site-directed mutagenesis. Prostaglandins Leukot Essent Fatty Acids (1998) 0.79
Dexamethasone inhibits the induction of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase by phorbol ester in human promonocytic U937 cells. Biochim Biophys Acta (2000) 0.79
Arachidonic acid and its metabolites in cerebral ischemia. Ann N Y Acad Sci (1989) 0.79
Stimulation of prostaglandin E2 synthesis by interleukin-1beta is amplified by interferons but inhibited by interleukin-4 in human amnion-derived WISH cells. Biochim Biophys Acta (1996) 0.79
Development of radioimmunoassay for motilin. Anal Biochem (1978) 0.79
Induction of fatty acid cyclooxygenase in rat aortic smooth muscle cells by estradiol. Prostaglandins Leukot Med (1983) 0.78
Diglyceride/monoglyceride lipases pathway is not essential for arachidonate release in thrombin-activated human platelets. Biochem Biophys Res Commun (1983) 0.78